Humana Inc. (NYSE:HUM) Shares Acquired by Leith Wheeler Investment Counsel Ltd.

Key Points

• Leith Wheeler Investment Counsel Ltd. increased its holdings in Humana Inc. by 6.9% in Q1, owning 136,363 shares valued at approximately $36.08 million.
• Various institutional investors have also raised their stakes in Humana, with Vanguard Group Inc. increasing holdings by 8.9% to nearly 14 million shares.
• Humana’s stock currently has an average rating of "Hold" and a consensus price target of $281.62, with notable price target changes from analysts.

Leith Wheeler Investment Counsel Ltd. increased its stake in Humana Inc. (NYSE:HUM - Free Report) by 6.9% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 136,363 shares of the insurance provider's stock after acquiring an additional 8,771 shares during the period. Humana makes up 2.5% of Leith Wheeler Investment Counsel Ltd.'s investment portfolio, making the stock its 8th largest position. Leith Wheeler Investment Counsel Ltd. owned about 0.11% of Humana worth $36,082,000 as of its most recent filing with the SEC.

Other hedge funds have also modified their holdings of the company. Dodge & Cox lifted its holdings in Humana by 106.7% in the fourth quarter. Dodge & Cox now owns 10,198,040 shares of the insurance provider's stock worth $2,587,345,000 after purchasing an additional 5,264,045 shares during the period. Vanguard Group Inc. lifted its holdings in Humana by 8.9% in the first quarter. Vanguard Group Inc. now owns 13,972,872 shares of the insurance provider's stock worth $3,697,222,000 after purchasing an additional 1,143,662 shares during the period. GAMMA Investing LLC lifted its holdings in Humana by 40,881.1% in the first quarter. GAMMA Investing LLC now owns 781,099 shares of the insurance provider's stock worth $2,066,790,000 after purchasing an additional 779,193 shares during the period. Southpoint Capital Advisors LP acquired a new stake in Humana in the fourth quarter worth about $190,282,000. Finally, Nuveen LLC bought a new stake in Humana in the first quarter worth about $171,220,000. 92.38% of the stock is owned by institutional investors and hedge funds.

Humana Stock Performance

Humana stock traded up $5.39 during trading hours on Friday, reaching $286.73. 1,738,591 shares of the company were exchanged, compared to its average volume of 2,075,797. The firm has a market cap of $34.49 billion, a price-to-earnings ratio of 22.01, a PEG ratio of 1.65 and a beta of 0.44. The company has a current ratio of 1.95, a quick ratio of 1.95 and a debt-to-equity ratio of 0.69. The stock has a 50-day moving average of $241.58 and a 200 day moving average of $253.94. Humana Inc. has a 12 month low of $206.87 and a 12 month high of $382.72.

Humana (NYSE:HUM - Get Free Report) last issued its quarterly earnings results on Wednesday, July 30th. The insurance provider reported $6.27 EPS for the quarter, missing analysts' consensus estimates of $6.32 by ($0.05). Humana had a return on equity of 13.67% and a net margin of 1.28%. The business had revenue of $32.39 billion for the quarter, compared to analyst estimates of $31.85 billion. During the same quarter last year, the firm earned $6.96 earnings per share. The firm's quarterly revenue was up 9.6% compared to the same quarter last year. As a group, research analysts anticipate that Humana Inc. will post 16.47 earnings per share for the current year.

Wall Street Analyst Weigh In

HUM has been the topic of several recent analyst reports. Wall Street Zen downgraded Humana from a "buy" rating to a "hold" rating in a report on Saturday, August 2nd. Piper Sandler cut their price objective on Humana from $288.00 to $272.00 and set a "neutral" rating on the stock in a report on Thursday, July 31st. Argus restated a "hold" rating and set a $281.99 price objective on shares of Humana in a report on Thursday. Raymond James Financial upgraded Humana from a "market perform" rating to an "outperform" rating and set a $315.00 price objective on the stock in a report on Thursday, May 1st. Finally, Truist Financial cut their price objective on Humana from $280.00 to $260.00 and set a "hold" rating on the stock in a report on Wednesday, July 16th. Eighteen equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of "Hold" and a consensus target price of $281.45.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.